Periostin	NN	PERIOSTIN NN PennPOS
promotes	VBZ	promote VBZ PennPOS
fibrosis	NN	fibrosis NN PennPOS
and	CC	and cc NUPOS
predicts	VBZ	predict VBZ PennPOS
progression	NN	progression NN PennPOS
in	IN	in IN PennPOS
patients	NNS	patient NNS PennPOS
with	IN	with pp NUPOS
idiopathic	JJ	idiopathic JJ PennPOS
pulmonary	JJ	pulmonary JJ PennPOS
fibrosis	NN	fibrosis NN PennPOS
.	.	. . NUPOS

Idiopathic	JJ	idiopathic JJ PennPOS
pulmonary	JJ	pulmonary JJ PennPOS
fibrosis	NN	fibrosis NN PennPOS
(	(	( ( NUPOS
IPF	NN	IPF NN PennPOS
)	)	) ) NUPOS
is	VBZ	be vbz NUPOS
a	DT	a dt NUPOS
progressive	JJ	progressive JJ PennPOS
fibrotic	JJ	fibrotic JJ PennPOS
lung	NN	lung NN PennPOS
disease	NN	disease NN PennPOS
without	IN	without IN PennPOS
effective	JJ	effective JJ PennPOS
therapeutics	NNS	therapeutic NNS PennPOS
.	.	. . NUPOS

Periostin	NNP	PERIOSTIN NN PennPOS
has	VBZ	have vdz NUPOS
been	VBN	be vbn NUPOS
reported	VBN	report VBN PennPOS
to	TO	to p-acp NUPOS
be	VB	be vbi NUPOS
elevated	JJ	elevated JJ PennPOS
in	IN	in IN PennPOS
IPF	NN	IPF NN PennPOS
patients	NNS	patient NNS PennPOS
relative	JJ	relative JJ PennPOS
to	TO	to p-acp NUPOS
controls	NNS	control NNS PennPOS
,	,	, , NUPOS
but	CC	but cc-acp NUPOS
its	PRP$	its po31 NUPOS
sources	NNS	source NNS PennPOS
and	CC	and cc NUPOS
mechanisms	NNS	mechanism NNS PennPOS
of	IN	of pp-f NUPOS
action	NN	action NN PennPOS
remain	VBP	remain VBP PennPOS
unclear	JJ	unclear JJ PennPOS
.	.	. . NUPOS

We	PRP	we pns12 NUPOS
confirm	VBP	confirm VBP PennPOS
excess	JJ	excess JJ PennPOS
periostin	NN	PERIOSTIN NN PennPOS
in	IN	in IN PennPOS
lungs	NNS	lung NNS PennPOS
of	IN	of pp-f NUPOS
IPF	NN	IPF NN PennPOS
patients	NNS	patient NNS PennPOS
and	CC	and cc NUPOS
show	VBP	show VBP PennPOS
that	IN	that cst NUPOS
IPF	NN	IPF NN PennPOS
fibroblasts	NNS	fibroblast NNS PennPOS
produce	VBP	produce VBP PennPOS
periostin	NN	PERIOSTIN NN PennPOS
.	.	. . NUPOS

Blood	NN	blood NN PennPOS
was	VBD	be vbd NUPOS
obtained	VBN	obtain VBN PennPOS
from	IN	from pp NUPOS
54	CD	54 crd NUPOS
IPF	NN	IPF NN PennPOS
patients	NNS	patient NNS PennPOS
(	(	( ( NUPOS
all	DT	all d NUPOS
but	CC	but cc-acp NUPOS
1	CD	1 crd NUPOS
with	IN	with pp NUPOS
48	CD	48 CD PennPOS
wk	NN	wk NN PennPOS
of	IN	of pp-f NUPOS
follow-up	NN	follow-up NN PennPOS
)	)	) ) NUPOS
.	.	. . NUPOS

We	PRP	we pns12 NUPOS
show	VBP	show VBP PennPOS
that	IN	that cst NUPOS
periostin	NN	PERIOSTIN NN PennPOS
levels	NNS	level NNS PennPOS
predict	VBP	predict VBP PennPOS
clinical	JJ	clinical JJ PennPOS
progression	NN	progression NN PennPOS
at	IN	at pp NUPOS
48	CD	48 CD PennPOS
wk	NN	wk NN PennPOS
(	(	( ( NUPOS
hazard	NN	hazard NN PennPOS
ratio	NN	ratio NN PennPOS
=	JJ	= JJ PennPOS
1.47	CD	1.47 CD PennPOS
,	,	, , NUPOS
95	CD	95 CD PennPOS
%	NN	% NN PennPOS
confidence	NN	confidence NN PennPOS
interval	NN	interval NN PennPOS
=	JJ	= JJ PennPOS
1.03-2.10	CD	1.03-2.10 CD PennPOS
,	,	, , NUPOS
P	NN	p NN PennPOS
<	JJR	< JJR PennPOS
0.05	CD	0.05 CD PennPOS
)	)	) ) NUPOS
.	.	. . NUPOS

Monocytes	NNS	monocyte NNS PennPOS
and	CC	and cc NUPOS
fibrocytes	NNS	fibrocyte NNS PennPOS
are	VBP	be vbb NUPOS
sources	NNS	source NNS PennPOS
of	IN	of pp-f NUPOS
periostin	NN	PERIOSTIN NN PennPOS
in	IN	in IN PennPOS
circulation	NN	circulation NN PennPOS
in	IN	in IN PennPOS
IPF	NN	IPF NN PennPOS
patients	NNS	patient NNS PennPOS
.	.	. . NUPOS

Previous	JJ	previous JJ PennPOS
studies	NNS	study NNS PennPOS
suggest	VBP	suggest VBP PennPOS
that	IN	that cst NUPOS
periostin	NN	PERIOSTIN NN PennPOS
may	MD	may vmb NUPOS
regulate	VB	regulate VBP PennPOS
the	DT	the dt NUPOS
inflammatory	JJ	inflammatory JJ PennPOS
phase	NN	phase NN PennPOS
of	IN	of pp-f NUPOS
bleomycin-induced	JJ	bleomycin-induced JJ PennPOS
lung	NN	lung NN PennPOS
injury	NN	injury NN PennPOS
,	,	, , NUPOS
but	CC	but cc-acp NUPOS
periostin	JJ	periostin JJ PennPOS
effects	NNS	effect NNS PennPOS
during	IN	during pp NUPOS
the	DT	the dt NUPOS
fibroproliferative	JJ	fibroproliferative JJ PennPOS
phase	NN	phase NN PennPOS
of	IN	of pp-f NUPOS
the	DT	the dt NUPOS
disease	NN	disease NN PennPOS
are	VBP	be vbb NUPOS
unknown	JJ	unknown JJ PennPOS
.	.	. . NUPOS

Wild-type	JJ	wild-type JJ PennPOS
and	CC	and cc NUPOS
periostin-deficient	JJ	periostin-deficient JJ PennPOS
(	(	( ( NUPOS
periostin	NN	PERIOSTIN NN PennPOS
(	(	( ( NUPOS
-	:	- : NUPOS
/	:	/ : NUPOS
-	:	- : NUPOS
)	)	) ) NUPOS
)	)	) ) NUPOS
mice	NNS	mouse n2 NUPOS
were	VBD	be vbd NUPOS
anesthetized	JJ	anesthetized JJ PennPOS
and	CC	and cc NUPOS
challenged	VBN	challenge vvn NUPOS
with	IN	with pp NUPOS
bleomycin	NN	bleomycin NN PennPOS
.	.	. . NUPOS

Wild-type	JJ	wild-type JJ PennPOS
mice	NNS	mouse n2 NUPOS
were	VBD	be vbd NUPOS
injected	VBN	inject VBN PennPOS
with	IN	with pp NUPOS
bleomycin	NN	bleomycin NN PennPOS
and	CC	and cc NUPOS
then	RB	then av NUPOS
treated	VBN	treat VBN PennPOS
with	IN	with pp NUPOS
OC-20	NN	OC-20 NN PennPOS
Ab	NN	ab NN PennPOS
(	(	( ( NUPOS
which	WDT	which r-crq NUPOS
blocks	VBZ	block VBZ PennPOS
periostin	NN	PERIOSTIN NN PennPOS
and	CC	and cc NUPOS
integrin	NN	integrin NN PennPOS
interactions	NNS	interaction NNS PennPOS
)	)	) ) NUPOS
or	CC	or cc NUPOS
control	NN	control NN PennPOS
Ab	NNS	ab NN PennPOS
during	IN	during pp NUPOS
the	DT	the dt NUPOS
fibroproliferative	JJ	fibroproliferative JJ PennPOS
phase	NN	phase NN PennPOS
of	IN	of pp-f NUPOS
disease	NN	disease NN PennPOS
,	,	, , NUPOS
and	CC	and cc NUPOS
fibrosis	NN	fibrosis NN PennPOS
and	CC	and cc NUPOS
survival	NN	survival NN PennPOS
were	VBD	be vbd NUPOS
assessed	VBN	assess VBN PennPOS
.	.	. . NUPOS

Periostin	NN	PERIOSTIN NN PennPOS
expression	NN	expression NN PennPOS
was	VBD	be vbd NUPOS
upregulated	VBN	upregulate VBN PennPOS
quickly	RB	quick av-j NUPOS
after	IN	after c-acp NUPOS
treatment	NN	treatment NN PennPOS
with	IN	with pp NUPOS
bleomycin	NN	bleomycin NN PennPOS
and	CC	and cc NUPOS
remained	VBD	remain VBD PennPOS
elevated	JJ	elevated JJ PennPOS
.	.	. . NUPOS

Periostin	NN	PERIOSTIN NN PennPOS
(	(	( ( NUPOS
-	:	- : NUPOS
/	:	/ : NUPOS
-	:	- : NUPOS
)	)	) ) NUPOS
mice	NNS	mouse n2 NUPOS
were	VBD	be vbd NUPOS
protected	VBN	protect VBN PennPOS
from	IN	from pp NUPOS
bleomycin-induced	JJ	bleomycin-induced JJ PennPOS
fibrosis	NN	fibrosis NN PennPOS
.	.	. . NUPOS

Instillation	NN	instillation NN PennPOS
of	IN	of pp-f NUPOS
OC-20	NN	OC-20 NN PennPOS
during	IN	during pp NUPOS
the	DT	the dt NUPOS
fibroproliferative	JJ	fibroproliferative JJ PennPOS
phase	NN	phase NN PennPOS
improved	VBD	improve VBD PennPOS
survival	NN	survival NN PennPOS
and	CC	and cc NUPOS
limited	JJ	limited JJ PennPOS
collagen	NN	collagen NN PennPOS
deposition	NN	deposition NN PennPOS
.	.	. . NUPOS

Chimeric	JJ	chimeric JJ PennPOS
mouse	NN	mouse NN PennPOS
studies	NNS	study NNS PennPOS
suggest	VBP	suggest VBP PennPOS
that	IN	that cst NUPOS
hematopoietic	JJ	hematopoietic JJ PennPOS
and	CC	and cc NUPOS
structural	JJ	structural JJ PennPOS
sources	NNS	source NNS PennPOS
of	IN	of pp-f NUPOS
periostin	NN	PERIOSTIN NN PennPOS
contribute	VBP	contribute VBP PennPOS
to	TO	to p-acp NUPOS
lung	NN	lung NN PennPOS
fibrogenesis	NN	fibrogenesis NN PennPOS
.	.	. . NUPOS

Periostin	NNP	PERIOSTIN NN PennPOS
was	VBD	be vbd NUPOS
upregulated	VBN	upregulate VBN PennPOS
by	IN	by IN PennPOS
transforming-growth-factor-b	NN	transforming-growth-factor-b NN PennPOS
in	IN	in IN PennPOS
lung	NN	lung NN PennPOS
mesenchymal	JJ	mesenchymal JJ PennPOS
cells	NNS	cell NNS PennPOS
,	,	, , NUPOS
and	CC	and cc NUPOS
periostin	NN	PERIOSTIN NN PennPOS
promoted	VBD	promote VBD PennPOS
extracellular	JJ	extracellular JJ PennPOS
matrix	NN	matrix NN PennPOS
deposition	NN	deposition NN PennPOS
,	,	, , NUPOS
mesenchymal	JJ	mesenchymal JJ PennPOS
cell	NN	cell NN PennPOS
proliferation	NN	proliferation NN PennPOS
,	,	, , NUPOS
and	CC	and cc NUPOS
wound	NN	wound NN PennPOS
closure	NN	closure NN PennPOS
.	.	. . NUPOS

Thus	RB	thus av NUPOS
periostin	NN	PERIOSTIN NN PennPOS
plays	VBZ	play VBZ PennPOS
a	DT	a dt NUPOS
vital	JJ	vital JJ PennPOS
role	NN	role NN PennPOS
in	IN	in IN PennPOS
late	JJ	late JJ PennPOS
stages	NNS	stage NNS PennPOS
of	IN	of pp-f NUPOS
pulmonary	JJ	pulmonary JJ PennPOS
fibrosis	NN	fibrosis NN PennPOS
and	CC	and cc NUPOS
is	VBZ	be vbz NUPOS
a	DT	a dt NUPOS
potential	JJ	potential JJ PennPOS
biomarker	NN	biomarker NN PennPOS
for	IN	for c-acp NUPOS
disease	NN	disease NN PennPOS
progression	NN	progression NN PennPOS
and	CC	and cc NUPOS
a	DT	a dt NUPOS
target	NN	target NN PennPOS
for	IN	for c-acp NUPOS
therapeutic	JJ	therapeutic JJ PennPOS
intervention	NN	intervention NN PennPOS
.	.	. . NUPOS

